+1 347 708 0418
The Biopharmaceutical 3PL market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Biopharmaceutical 3PL size is estimated to be USD XX million in 2026 from USD XX million in 2020, with a change XX% between 2020 and 2021. The global Biopharmaceutical 3PL market size is expected to grow at a CAGR of XX% for the next five years.
Market segmentation
Biopharmaceutical 3PL market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cold Chain
Non-cold Chain
Market segment by Application, can be divided into
Transportation
Warehousing and Storage
Others
Market segment by players, this report covers
FedEx.
DHL International GmbH
SF Express
United Parcel Service of America, Inc.
AmerisourceBergen Corporation
DB Schenker
KUEHNE + NAGEL
Kerry Logistics Network Limited
Agility
EMS
SF Express
Jd.Com, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biopharmaceutical 3PL product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biopharmaceutical 3PL, with revenue, gross margin and global market share of Biopharmaceutical 3PL from 2019 to 2021.
Chapter 3, the Biopharmaceutical 3PL competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Biopharmaceutical 3PL market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Biopharmaceutical 3PL research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Biopharmaceutical 3PL
1.2 Classification of Biopharmaceutical 3PL by Type
1.2.1 Overview: Global Biopharmaceutical 3PL Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Biopharmaceutical 3PL Revenue Market Share by Type in 2020
1.2.3 Cold Chain
1.2.4 Non-cold Chain
1.3 Global Biopharmaceutical 3PL Market by Application
1.3.1 Overview: Global Biopharmaceutical 3PL Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Transportation
1.3.3 Warehousing and Storage
1.3.4 Others
1.4 Global Biopharmaceutical 3PL Market Size & Forecast
1.5 Global Biopharmaceutical 3PL Market Size and Forecast by Region
1.5.1 Global Biopharmaceutical 3PL Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Biopharmaceutical 3PL Market Size by Region, (2016-2021)
1.5.3 North America Biopharmaceutical 3PL Market Size and Prospect (2016-2026)
1.5.4 Europe Biopharmaceutical 3PL Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Biopharmaceutical 3PL Market Size and Prospect (2016-2026)
1.5.6 South America Biopharmaceutical 3PL Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Biopharmaceutical 3PL Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Biopharmaceutical 3PL Market Drivers
1.6.2 Biopharmaceutical 3PL Market Restraints
1.6.3 Biopharmaceutical 3PL Trends Analysis
2 Company Profiles
2.1 FedEx.
2.1.1 FedEx. Details
2.1.2 FedEx. Major Business
2.1.3 FedEx. Biopharmaceutical 3PL Product and Solutions
2.1.4 FedEx. Biopharmaceutical 3PL Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 FedEx. Recent Developments and Future Plans
2.2 DHL International GmbH
2.2.1 DHL International GmbH Details
2.2.2 DHL International GmbH Major Business
2.2.3 DHL International GmbH Biopharmaceutical 3PL Product and Solutions
2.2.4 DHL International GmbH Biopharmaceutical 3PL Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 DHL International GmbH Recent Developments and Future Plans
2.3 SF Express
2.3.1 SF Express Details
2.3.2 SF Express Major Business
2.3.3 SF Express Biopharmaceutical 3PL Product and Solutions
2.3.4 SF Express Biopharmaceutical 3PL Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 SF Express Recent Developments and Future Plans
2.4 United Parcel Service of America, Inc.
2.4.1 United Parcel Service of America, Inc. Details
2.4.2 United Parcel Service of America, Inc. Major Business
2.4.3 United Parcel Service of America, Inc. Biopharmaceutical 3PL Product and Solutions
2.4.4 United Parcel Service of America, Inc. Biopharmaceutical 3PL Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 United Parcel Service of America, Inc. Recent Developments and Future Plans
2.5 AmerisourceBergen Corporation
2.5.1 AmerisourceBergen Corporation Details
2.5.2 AmerisourceBergen Corporation Major Business
2.5.3 AmerisourceBergen Corporation Biopharmaceutical 3PL Product and Solutions
2.5.4 AmerisourceBergen Corporation Biopharmaceutical 3PL Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 AmerisourceBergen Corporation Recent Developments and Future Plans
2.6 DB Schenker
2.6.1 DB Schenker Details
2.6.2 DB Schenker Major Business
2.6.3 DB Schenker Biopharmaceutical 3PL Product and Solutions
2.6.4 DB Schenker Biopharmaceutical 3PL Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 DB Schenker Recent Developments and Future Plans
2.7 KUEHNE + NAGEL
2.7.1 KUEHNE + NAGEL Details
2.7.2 KUEHNE + NAGEL Major Business
2.7.3 KUEHNE + NAGEL Biopharmaceutical 3PL Product and Solutions
2.7.4 KUEHNE + NAGEL Biopharmaceutical 3PL Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 KUEHNE + NAGEL Recent Developments and Future Plans
2.8 Kerry Logistics Network Limited
2.8.1 Kerry Logistics Network Limited Details
2.8.2 Kerry Logistics Network Limited Major Business
2.8.3 Kerry Logistics Network Limited Biopharmaceutical 3PL Product and Solutions
2.8.4 Kerry Logistics Network Limited Biopharmaceutical 3PL Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Kerry Logistics Network Limited Recent Developments and Future Plans
2.9 Agility
2.9.1 Agility Details
2.9.2 Agility Major Business
2.9.3 Agility Biopharmaceutical 3PL Product and Solutions
2.9.4 Agility Biopharmaceutical 3PL Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Agility Recent Developments and Future Plans
2.10 EMS
2.10.1 EMS Details
2.10.2 EMS Major Business
2.10.3 EMS Biopharmaceutical 3PL Product and Solutions
2.10.4 EMS Biopharmaceutical 3PL Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 EMS Recent Developments and Future Plans
2.11 SF Express
2.11.1 SF Express Details
2.11.2 SF Express Major Business
2.11.3 SF Express Biopharmaceutical 3PL Product and Solutions
2.11.4 SF Express Biopharmaceutical 3PL Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 SF Express Recent Developments and Future Plans
2.12 Jd.Com, Inc.
2.12.1 Jd.Com, Inc. Details
2.12.2 Jd.Com, Inc. Major Business
2.12.3 Jd.Com, Inc. Biopharmaceutical 3PL Product and Solutions
2.12.4 Jd.Com, Inc. Biopharmaceutical 3PL Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Jd.Com, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biopharmaceutical 3PL Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Biopharmaceutical 3PL Players Market Share
3.2.2 Top 10 Biopharmaceutical 3PL Players Market Share
3.2.3 Market Competition Trend
3.3 Biopharmaceutical 3PL Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Biopharmaceutical 3PL Revenue and Market Share by Type (2016-2021)
4.2 Global Biopharmaceutical 3PL Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Biopharmaceutical 3PL Revenue Market Share by Application (2016-2021)
5.2 Biopharmaceutical 3PL Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Biopharmaceutical 3PL Revenue by Type (2016-2026)
6.2 North America Biopharmaceutical 3PL Revenue by Application (2016-2026)
6.3 North America Biopharmaceutical 3PL Market Size by Country
6.3.1 North America Biopharmaceutical 3PL Revenue by Country (2016-2026)
6.3.2 United States Biopharmaceutical 3PL Market Size and Forecast (2016-2026)
6.3.3 Canada Biopharmaceutical 3PL Market Size and Forecast (2016-2026)
6.3.4 Mexico Biopharmaceutical 3PL Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Biopharmaceutical 3PL Revenue by Type (2016-2026)
7.2 Europe Biopharmaceutical 3PL Revenue by Application (2016-2026)
7.3 Europe Biopharmaceutical 3PL Market Size by Country
7.3.1 Europe Biopharmaceutical 3PL Revenue by Country (2016-2026)
7.3.2 Germany Biopharmaceutical 3PL Market Size and Forecast (2016-2026)
7.3.3 France Biopharmaceutical 3PL Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Biopharmaceutical 3PL Market Size and Forecast (2016-2026)
7.3.5 Russia Biopharmaceutical 3PL Market Size and Forecast (2016-2026)
7.3.6 Italy Biopharmaceutical 3PL Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Biopharmaceutical 3PL Revenue by Type (2016-2026)
8.2 Asia-Pacific Biopharmaceutical 3PL Revenue by Application (2016-2026)
8.3 Asia-Pacific Biopharmaceutical 3PL Market Size by Region
8.3.1 Asia-Pacific Biopharmaceutical 3PL Revenue by Region (2016-2026)
8.3.2 China Biopharmaceutical 3PL Market Size and Forecast (2016-2026)
8.3.3 Japan Biopharmaceutical 3PL Market Size and Forecast (2016-2026)
8.3.4 South Korea Biopharmaceutical 3PL Market Size and Forecast (2016-2026)
8.3.5 India Biopharmaceutical 3PL Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Biopharmaceutical 3PL Market Size and Forecast (2016-2026)
8.3.7 Australia Biopharmaceutical 3PL Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Biopharmaceutical 3PL Revenue by Type (2016-2026)
9.2 South America Biopharmaceutical 3PL Revenue by Application (2016-2026)
9.3 South America Biopharmaceutical 3PL Market Size by Country
9.3.1 South America Biopharmaceutical 3PL Revenue by Country (2016-2026)
9.3.2 Brazil Biopharmaceutical 3PL Market Size and Forecast (2016-2026)
9.3.3 Argentina Biopharmaceutical 3PL Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Biopharmaceutical 3PL Revenue by Type (2016-2026)
10.2 Middle East & Africa Biopharmaceutical 3PL Revenue by Application (2016-2026)
10.3 Middle East & Africa Biopharmaceutical 3PL Market Size by Country
10.3.1 Middle East & Africa Biopharmaceutical 3PL Revenue by Country (2016-2026)
10.3.2 Turkey Biopharmaceutical 3PL Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Biopharmaceutical 3PL Market Size and Forecast (2016-2026)
10.3.4 UAE Biopharmaceutical 3PL Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Biopharmaceutical 3PL Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Biopharmaceutical 3PL Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Biopharmaceutical 3PL Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Biopharmaceutical 3PL Revenue (USD Million) by Region (2016-2021)
Table 5. Global Biopharmaceutical 3PL Revenue Market Share by Region (2021-2026)
Table 6. FedEx. Corporate Information, Head Office, and Major Competitors
Table 7. FedEx. Major Business
Table 8. FedEx. Biopharmaceutical 3PL Product and Solutions
Table 9. FedEx. Biopharmaceutical 3PL Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. DHL International GmbH Corporate Information, Head Office, and Major Competitors
Table 11. DHL International GmbH Major Business
Table 12. DHL International GmbH Biopharmaceutical 3PL Product and Solutions
Table 13. DHL International GmbH Biopharmaceutical 3PL Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. SF Express Corporate Information, Head Office, and Major Competitors
Table 15. SF Express Major Business
Table 16. SF Express Biopharmaceutical 3PL Product and Solutions
Table 17. SF Express Biopharmaceutical 3PL Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. United Parcel Service of America, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. United Parcel Service of America, Inc. Major Business
Table 20. United Parcel Service of America, Inc. Biopharmaceutical 3PL Product and Solutions
Table 21. United Parcel Service of America, Inc. Biopharmaceutical 3PL Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. AmerisourceBergen Corporation Corporate Information, Head Office, and Major Competitors
Table 23. AmerisourceBergen Corporation Major Business
Table 24. AmerisourceBergen Corporation Biopharmaceutical 3PL Product and Solutions
Table 25. AmerisourceBergen Corporation Biopharmaceutical 3PL Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. DB Schenker Corporate Information, Head Office, and Major Competitors
Table 27. DB Schenker Major Business
Table 28. DB Schenker Biopharmaceutical 3PL Product and Solutions
Table 29. DB Schenker Biopharmaceutical 3PL Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. KUEHNE + NAGEL Corporate Information, Head Office, and Major Competitors
Table 31. KUEHNE + NAGEL Major Business
Table 32. KUEHNE + NAGEL Biopharmaceutical 3PL Product and Solutions
Table 33. KUEHNE + NAGEL Biopharmaceutical 3PL Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Kerry Logistics Network Limited Corporate Information, Head Office, and Major Competitors
Table 35. Kerry Logistics Network Limited Major Business
Table 36. Kerry Logistics Network Limited Biopharmaceutical 3PL Product and Solutions
Table 37. Kerry Logistics Network Limited Biopharmaceutical 3PL Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Agility Corporate Information, Head Office, and Major Competitors
Table 39. Agility Major Business
Table 40. Agility Biopharmaceutical 3PL Product and Solutions
Table 41. Agility Biopharmaceutical 3PL Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. EMS Corporate Information, Head Office, and Major Competitors
Table 43. EMS Major Business
Table 44. EMS Biopharmaceutical 3PL Product and Solutions
Table 45. EMS Biopharmaceutical 3PL Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. SF Express Corporate Information, Head Office, and Major Competitors
Table 47. SF Express Major Business
Table 48. SF Express Biopharmaceutical 3PL Product and Solutions
Table 49. SF Express Biopharmaceutical 3PL Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Jd.Com, Inc. Corporate Information, Head Office, and Major Competitors
Table 51. Jd.Com, Inc. Major Business
Table 52. Jd.Com, Inc. Biopharmaceutical 3PL Product and Solutions
Table 53. Jd.Com, Inc. Biopharmaceutical 3PL Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global Biopharmaceutical 3PL Revenue (USD Million) by Players (2019-2021)
Table 55. Global Biopharmaceutical 3PL Revenue Share by Players (2019-2021)
Table 56. Breakdown of Biopharmaceutical 3PL by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Biopharmaceutical 3PL Players Head Office, Products and Services Provided
Table 58. Biopharmaceutical 3PL Mergers & Acquisitions in the Past Five Years
Table 59. Biopharmaceutical 3PL New Entrants and Expansion Plans
Table 60. Global Biopharmaceutical 3PL Revenue (USD Million) by Type (2016-2021)
Table 61. Global Biopharmaceutical 3PL Revenue Share by Type (2016-2021)
Table 62. Global Biopharmaceutical 3PL Revenue Forecast by Type (2021-2026)
Table 63. Global Biopharmaceutical 3PL Revenue by Application (2016-2021)
Table 64. Global Biopharmaceutical 3PL Revenue Forecast by Application (2021-2026)
Table 65. North America Biopharmaceutical 3PL Revenue by Type (2016-2021) & (USD Million)
Table 66. North America Biopharmaceutical 3PL Revenue by Type (2021-2026) & (USD Million)
Table 67. North America Biopharmaceutical 3PL Revenue by Application (2016-2021) & (USD Million)
Table 68. North America Biopharmaceutical 3PL Revenue by Application (2021-2026) & (USD Million)
Table 69. North America Biopharmaceutical 3PL Revenue by Country (2016-2021) & (USD Million)
Table 70. North America Biopharmaceutical 3PL Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe Biopharmaceutical 3PL Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe Biopharmaceutical 3PL Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe Biopharmaceutical 3PL Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe Biopharmaceutical 3PL Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe Biopharmaceutical 3PL Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe Biopharmaceutical 3PL Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific Biopharmaceutical 3PL Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific Biopharmaceutical 3PL Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific Biopharmaceutical 3PL Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific Biopharmaceutical 3PL Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific Biopharmaceutical 3PL Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific Biopharmaceutical 3PL Revenue by Region (2021-2026) & (USD Million)
Table 83. South America Biopharmaceutical 3PL Revenue by Type (2016-2021) & (USD Million)
Table 84. South America Biopharmaceutical 3PL Revenue by Type (2021-2026) & (USD Million)
Table 85. South America Biopharmaceutical 3PL Revenue by Application (2016-2021) & (USD Million)
Table 86. South America Biopharmaceutical 3PL Revenue by Application (2021-2026) & (USD Million)
Table 87. South America Biopharmaceutical 3PL Revenue by Country (2016-2021) & (USD Million)
Table 88. South America Biopharmaceutical 3PL Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Biopharmaceutical 3PL Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa Biopharmaceutical 3PL Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa Biopharmaceutical 3PL Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa Biopharmaceutical 3PL Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa Biopharmaceutical 3PL Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa Biopharmaceutical 3PL Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Biopharmaceutical 3PL Picture
Figure 2. Global Biopharmaceutical 3PL Revenue Market Share by Type in 2020
Figure 3. Cold Chain
Figure 4. Non-cold Chain
Figure 5. Biopharmaceutical 3PL Revenue Market Share by Application in 2020
Figure 6. Transportation Picture
Figure 7. Warehousing and Storage Picture
Figure 8. Others Picture
Figure 9. Global Biopharmaceutical 3PL Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Biopharmaceutical 3PL Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Biopharmaceutical 3PL Revenue Market Share by Region (2016-2026)
Figure 12. Global Biopharmaceutical 3PL Revenue Market Share by Region in 2020
Figure 13. North America Biopharmaceutical 3PL Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Biopharmaceutical 3PL Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Biopharmaceutical 3PL Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Biopharmaceutical 3PL Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Biopharmaceutical 3PL Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Biopharmaceutical 3PL Market Drivers
Figure 19. Biopharmaceutical 3PL Market Restraints
Figure 20. Biopharmaceutical 3PL Market Trends
Figure 21. FedEx. Recent Developments and Future Plans
Figure 22. DHL International GmbH Recent Developments and Future Plans
Figure 23. SF Express Recent Developments and Future Plans
Figure 24. United Parcel Service of America, Inc. Recent Developments and Future Plans
Figure 25. AmerisourceBergen Corporation Recent Developments and Future Plans
Figure 26. DB Schenker Recent Developments and Future Plans
Figure 27. KUEHNE + NAGEL Recent Developments and Future Plans
Figure 28. Kerry Logistics Network Limited Recent Developments and Future Plans
Figure 29. Agility Recent Developments and Future Plans
Figure 30. EMS Recent Developments and Future Plans
Figure 31. SF Express Recent Developments and Future Plans
Figure 32. Jd.Com, Inc. Recent Developments and Future Plans
Figure 33. Global Biopharmaceutical 3PL Revenue Share by Players in 2020
Figure 34. Biopharmaceutical 3PL Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Biopharmaceutical 3PL Revenue Market Share in 2020
Figure 36. Global Top 10 Players Biopharmaceutical 3PL Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Biopharmaceutical 3PL Revenue Share by Type in 2020
Figure 39. Global Biopharmaceutical 3PL Market Share Forecast by Type (2021-2026)
Figure 40. Global Biopharmaceutical 3PL Revenue Share by Application in 2020
Figure 41. Global Biopharmaceutical 3PL Market Share Forecast by Application (2021-2026)
Figure 42. North America Biopharmaceutical 3PL Sales Market Share by Type (2016-2026)
Figure 43. North America Biopharmaceutical 3PL Sales Market Share by Application (2016-2026)
Figure 44. North America Biopharmaceutical 3PL Revenue Market Share by Country (2016-2026)
Figure 45. United States Biopharmaceutical 3PL Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Biopharmaceutical 3PL Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Biopharmaceutical 3PL Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Biopharmaceutical 3PL Sales Market Share by Type (2016-2026)
Figure 49. Europe Biopharmaceutical 3PL Sales Market Share by Application (2016-2026)
Figure 50. Europe Biopharmaceutical 3PL Revenue Market Share by Country (2016-2026)
Figure 51. Germany Biopharmaceutical 3PL Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Biopharmaceutical 3PL Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Biopharmaceutical 3PL Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Biopharmaceutical 3PL Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Biopharmaceutical 3PL Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Biopharmaceutical 3PL Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Biopharmaceutical 3PL Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Biopharmaceutical 3PL Revenue Market Share by Region (2016-2026)
Figure 59. China Biopharmaceutical 3PL Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Biopharmaceutical 3PL Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Biopharmaceutical 3PL Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Biopharmaceutical 3PL Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Biopharmaceutical 3PL Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Biopharmaceutical 3PL Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Biopharmaceutical 3PL Sales Market Share by Type (2016-2026)
Figure 66. South America Biopharmaceutical 3PL Sales Market Share by Application (2016-2026)
Figure 67. South America Biopharmaceutical 3PL Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Biopharmaceutical 3PL Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Biopharmaceutical 3PL Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Biopharmaceutical 3PL Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Biopharmaceutical 3PL Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Biopharmaceutical 3PL Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Biopharmaceutical 3PL Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Biopharmaceutical 3PL Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Biopharmaceutical 3PL Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
Buy
